The plan involves transferring production lines and cutting jobs, following a slowdown in two of the company’s key product lines.
Boston Scientific to restructure, taking up to $800M in charges
The plan involves transferring production lines and cutting jobs, following a slowdown in two of the company’s key product lines.
Source: MedTech Dive